Randomized, Double‐Blind, Placebo‐Controlled, Phase 2 Trial of BMS‐986020, a Lysophosphatidic Acid Receptor Antagonist for the Treatment of Idiopathic Pulmonary Fibrosis
暂无分享,去创建一个
K. Anstrom | G. Rosen | B. Soule | L. Snyder | S. Palmer | J. Todd | R. Gagnon | Yi Luo | R. Christian